ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Hampshire » Ophthalmology

Top Ophthalmology Prescribers in New Hampshire

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID BELLOWS MD

Ophthalmology

2,897

$210K

379
343 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

63%
prescriptions for brand name drugs

Avg: 61%

$73
Average prescription price

Avg: $77

ANDRE D'HEMECOURT M.D.

Ophthalmology

2,822

$233K

452
410 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

62%
prescriptions for brand name drugs

Avg: 61%

$83
Average prescription price

Avg: $77

DAVID CAMPBELL M.D.

Ophthalmology

2,411

$182K

302
284 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

61%
prescriptions for brand name drugs

Avg: 61%

$75
Average prescription price

Avg: $77

JYOTSOM GANATRA MD MPU

Ophthalmology

2,357

$141K

507
479 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 61%

$60
Average prescription price

Avg: $77

ADAM BECK MD

Ophthalmology

1,920

$101K

208
167 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 61%

$53
Average prescription price

Avg: $77

LAWRENCE JAEGER MD

Ophthalmology

1,832

$129K

331
316 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

67%
prescriptions for brand name drugs

Avg: 61%

$70
Average prescription price

Avg: $77

CHARLES WINGATE M.D.

Ophthalmology

1,663

$156K

285
261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

75%
prescriptions for brand name drugs

Avg: 61%

$94
Average prescription price

Avg: $77

ERIN FOGEL M.D.

Ophthalmology

1,644

$115K

334
295 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

74%
prescriptions for brand name drugs

Avg: 61%

$70
Average prescription price

Avg: $77

GEORGE SHAKER MD

Ophthalmology

1,581

$91.8K

314
285 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

62%
prescriptions for brand name drugs

Avg: 61%

$58
Average prescription price

Avg: $77

RANDALL BROWN MD

Ophthalmology

1,580

$128K

285
262 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

62%
prescriptions for brand name drugs

Avg: 61%

$81
Average prescription price

Avg: $77

DAVID CORBIT MD

Ophthalmology

1,552

$149K

256
233 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

62%
prescriptions for brand name drugs

Avg: 61%

$96
Average prescription price

Avg: $77

BRADFORD HALL MD

Ophthalmology

1,533

$120K

321
282 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 61%

$78
Average prescription price

Avg: $77

PETER WASSERMAN MD

Ophthalmology

1,487

$96.1K

300
268 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

66%
prescriptions for brand name drugs

Avg: 61%

$65
Average prescription price

Avg: $77

RICHARD LASONDE MD

Ophthalmology

1,465

$166K

301
266 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

69%
prescriptions for brand name drugs

Avg: 61%

$113
Average prescription price

Avg: $77

BASILIO KALPAKIAN M.D.

Ophthalmology

1,418

$122K

251
221 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

70%
prescriptions for brand name drugs

Avg: 61%

$86
Average prescription price

Avg: $77

SONALEE DESAI-BARTOLI M.D.

Ophthalmology

1,393

$113K

265
231 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

71%
prescriptions for brand name drugs

Avg: 61%

$81
Average prescription price

Avg: $77

THEODORE RENNA

Ophthalmology

1,374

$99.8K

235
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

57%
prescriptions for brand name drugs

Avg: 61%

$73
Average prescription price

Avg: $77

CATHRYN WELCH

Ophthalmology

1,293

$120K

250
236 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

65%
prescriptions for brand name drugs

Avg: 61%

$93
Average prescription price

Avg: $77

JOHN DAGIANIS M.D.

Ophthalmology

1,269

$151K

293
269 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

72%
prescriptions for brand name drugs

Avg: 61%

$119
Average prescription price

Avg: $77

MARK SZAL MD

Ophthalmology

1,257

$98.8K

279
240 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

70%
prescriptions for brand name drugs

Avg: 61%

$79
Average prescription price

Avg: $77

WILLIAM MARSH MD

Ophthalmology

1,148

$104K

235
221 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

68%
prescriptions for brand name drugs

Avg: 61%

$90
Average prescription price

Avg: $77

PAUL PENDER MD

Ophthalmology

1,123

$106K

229
214 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

69%
prescriptions for brand name drugs

Avg: 61%

$95
Average prescription price

Avg: $77

DOUGLAS SCOTT MD

Ophthalmology

1,049

$91.8K

253
229 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

59%
prescriptions for brand name drugs

Avg: 61%

$88
Average prescription price

Avg: $77

TIMOTHY BLAKE M.D.

Ophthalmology

1,034

$60.3K

259
213 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 61%

$58
Average prescription price

Avg: $77

PATRICK RIDDLE M.D.

Ophthalmology

923

$62.5K

234
209 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 61%

$68
Average prescription price

Avg: $77

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank